In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can ...

Q1 2025 Earnings Call Transcript May 8, 2025 Royalty Pharma plc beats earnings expectations. Reported EPS is $1.06, ...

Q1 2025 Earnings Call Transcript May 8, 2025 Crinetics Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug ...

In April 2025, our partner Jazz announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

Despite short-term challenges, Jain highlighted that Syngene’s diversified offerings across the drug development value chain allow it to navigate sectoral volatility. “Our broad-based ...

DELFI Diagnostics has clinically validated FirstLook Lung, its blood test designed to improve early detection of lung cancer, ...

Q1 2025 Earnings Conference Call May 8, 2025 7:30 AM ETCompany ParticipantsFabrice Chouraqui – CEOStephen Toor – ...

Ugur Sahin; Chief Executive Officer, Member of the Management Board; Biontech SE Oezlem Tuereci; Chief Medical Office, Member of the Management Board; Biontech SE Welcome to BioNTech's first-quarter ...